Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $273.82 million. The enterprise value is $284.09 million.
Important Dates
The next confirmed earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 70.21 million shares outstanding. The number of shares has increased by 6.68% in one year.
| Current Share Class | 70.21M |
| Shares Outstanding | 70.21M |
| Shares Change (YoY) | +6.68% |
| Shares Change (QoQ) | +3.20% |
| Owned by Insiders (%) | 2.88% |
| Owned by Institutions (%) | 76.63% |
| Float | 68.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.29 |
| PS Ratio | 0.77 |
| Forward PS | 0.80 |
| PB Ratio | 0.68 |
| P/TBV Ratio | 14.12 |
| P/FCF Ratio | 21.16 |
| P/OCF Ratio | 18.81 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 21.95 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 1.10.
| Current Ratio | 1.43 |
| Quick Ratio | 1.38 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | 31.08 |
| Interest Coverage | -3.34 |
Financial Efficiency
Return on equity (ROE) is -18.99% and return on invested capital (ROIC) is -5.16%.
| Return on Equity (ROE) | -18.99% |
| Return on Assets (ROA) | -4.57% |
| Return on Invested Capital (ROIC) | -5.16% |
| Return on Capital Employed (ROCE) | -10.71% |
| Revenue Per Employee | $204,389 |
| Profits Per Employee | -$46,335 |
| Employee Count | 1,500 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $333,000 in taxes.
| Income Tax | 333,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.59% in the last 52 weeks. The beta is 1.44, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -29.59% |
| 50-Day Moving Average | 4.46 |
| 200-Day Moving Average | 6.64 |
| Relative Strength Index (RSI) | 44.25 |
| Average Volume (20 Days) | 626,914 |
Short Selling Information
The latest short interest is 3.12 million, so 4.44% of the outstanding shares have been sold short.
| Short Interest | 3.12M |
| Short Previous Month | 2.94M |
| Short % of Shares Out | 4.44% |
| Short % of Float | 4.57% |
| Short Ratio (days to cover) | 3.53 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $306.58 million and -$69.50 million in losses. Loss per share was -$1.15.
| Revenue | 306.58M |
| Gross Profit | 141.79M |
| Operating Income | -57.10M |
| Pretax Income | -86.06M |
| Net Income | -69.50M |
| EBITDA | -25.37M |
| EBIT | -57.10M |
| Loss Per Share | -$1.15 |
Full Income StatementBalance Sheet
The company has $392.00 million in cash and $402.27 million in debt, giving a net cash position of -$10.27 million or -$0.15 per share.
| Cash & Cash Equivalents | 392.00M |
| Total Debt | 402.27M |
| Net Cash | -10.27M |
| Net Cash Per Share | -$0.15 |
| Equity (Book Value) | 365.21M |
| Book Value Per Share | 5.70 |
| Working Capital | 139.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $14.56 million and capital expenditures -$1.62 million, giving a free cash flow of $12.94 million.
| Operating Cash Flow | 14.56M |
| Capital Expenditures | -1.62M |
| Free Cash Flow | 12.94M |
| FCF Per Share | $0.18 |
Full Cash Flow StatementMargins
Gross margin is 46.25%, with operating and profit margins of -18.62% and -22.67%.
| Gross Margin | 46.25% |
| Operating Margin | -18.62% |
| Pretax Margin | -22.56% |
| Profit Margin | -22.67% |
| EBITDA Margin | -8.27% |
| EBIT Margin | -18.62% |
| FCF Margin | 4.22% |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.68% |
| Shareholder Yield | -6.68% |
| Earnings Yield | -25.38% |
| FCF Yield | 4.73% |
Analyst Forecast
The average price target for Health Catalyst is $8.36, which is 113.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.36 |
| Price Target Difference | 113.54% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 11.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -1.05 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.05 |
| Piotroski F-Score | 4 |